Saudi Arabia Veterinary Vaccine Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Livestock Vaccines (Bovine Vaccines, Poultry Vaccines, Others), Companion Animal Vaccines (Canine Vaccines, Feline Vaccines, Equine Vaccines)), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), And By Route of Administration (Injectable Vaccines, Intranasal Vaccines) - Forecasts From 2022 To 2027

Description

Saudi Arabia Veterinary Vaccine Market Size:

The Saudi Arabia Veterinary Vaccine Market is anticipated to expand at a high CAGR over the forecast period.

Saudi Arabia's Veterinary market growth is attributed to the increase in awareness of veterinary healthcare, improved animal husbandry measures, and equivalent increases in animal ownership are all key drivers for the fast-growing animal vaccines market penetration in the country. Camels are an integral part of life on the Arabian Peninsula, where camel racing and show pageants showcase the pedigree of animals that are purchased and sold at auction for huge sums. Due to growing issues about animal health, vaccines are also projected to see a significant rise in the coming years. As disease-prevention medicines evolve, the development of animal vaccinations is driving the market growth. Due to a growth in the number of livestock diseases, the pharmaceuticals business is predicted to grow dramatically over the forecast period, as this has propelled the government and major players to invest in the market.

Saudi Arabia Veterinary Vaccine Market Overview & Scope

The Saudi Arabia Veterinary Vaccine Market is segmented by:

• Type: The livestock vaccine holds the major share in the Saudi Arabian veterinary vaccine market, driven by the growing demand for meat and dairy-related products in the country, coupled with population growth and shift in dietary trends like demand for protein, which has increased in the livestock sector, which will promote the livestock vaccine segment demand.
• Technology: The inactivated vaccine segment is expected to expand at a substantial pace in the Saudi Arabian market due to its property of being safer and more stable than live attenuated vaccines, eliminating the risk of reversion to virulence.
• Disease: The zoonotic disease is the fastest-growing segment in the disease of the Saudi Arabian Veterinary vaccine market, driven by growing concern for the prevention of animal-to-human transmission. The demand for vaccination is expected to grow due to preventing threats to both animal health and public safety in the country.
• Route of Administration: The injectable vaccines segment is anticipated to hold the largest share in the route of administration segment because of the ease of administration of the drug, along with the high bioavailability, and is ideal for mass vaccination in livestock, especially cattle and camels.

Top Trends Shaping the Saudi Arabia Veterinary Vaccine Market

1. Increase in Government Investments in Veterinary Infrastructure
   The government under Vision 2030 and other initiatives for welfare in animal health is working towards an increase in the production of vaccines domestically, along with growth in veterinary care facilities, which will promote the market.

Saudi Arabia Veterinary Vaccine Market Growth Drivers vs. Challenges

Drivers:

• Increased R&D Investments in Animal Immunization: Some of the important driving factors responsible for market expansion are technical developments and the consequent introduction of animal vaccines. Since they were first presented to the general public, animal immunization has experienced significant R&D advancements. Animal immunization with pathogens that have been routinely attenuated and inactivated has made significant contributions to the protection of animal and human health.

The government announced that a new veterinary healthcare platform will open in Abu Dhabi in April 2022, marking a significant milestone for the nation's animal healthcare business. A cutting-edge vaccine production facility and two state-of-the-art veterinary clinics will form the foundation of the medical platform. The facilities will strengthen Abu Dhabi's status as a regional superpower in high-end veterinary care for horses and camels, as well as provide the most advanced technological animal vaccinations for the Middle East and Africa (MEA) area, once they are functional. Companies are taking advantage of Abu Dhabi's great potential market for animal vaccine production while also ensuring the health and well-being of treasured animals such as horses and camels by forming a joint venture with E20.

Furthermore, an increase in the number of livestock exports in the country will further propel the market growth during the projected timeframe. For instance, Sudan stated in April 2022 that it started exporting livestock to Saudi Arabia, the country's primary export, after extending a health protocol. According to government data, Sudan has more than 107 million cattle, and livestock exports are a significant source of foreign exchange, raking in over $1 billion in revenue.

• Increasing Initiatives for Animal Disease Prevention: Vaccines continue to play an increasingly important role in animal disease prevention and control programs. Pets and farm animals continue to benefit from critical medications that prevent or reduce clinical indications of disease owing to innovative research and the creation of safe, effective, and high-quality vaccinations. Although the pet market is not that prevalent in Saudi Arabia, but has a huge number of stray animals and farm animals. The high number of stray cats, dogs, and other animals has led to several rescue centres and shelters. For instance, the Royal Commission of Africa announced a program for saving the lives of stray animals in the region and was under the AlUla Animal Welfare Centre in September 2023. The aim was for the welfare of stray animals by decreasing their population, along with the prevention of diseases through suitable vaccination of these animals.

Challenges:

• Strict Regulatory Compliance: The stringent safety and efficacy standards for veterinary vaccines in the country require the manufacturers to meet rigorous regulatory frameworks, increasing production costs and time-to-commercialize the product, which could hamper the market.

Saudi Arabia Veterinary Vaccine Market Competitive Landscape

The market is fragmented, with many notable players, including Boehringer Ingelheim International GmbH, Virbac, Al-Emar International (ARASCO), and Alkhoraif Veterinary Company, among others.

• Vaccine Development and Localization: In July 2024, the Saudi Arabian Environment Minister announced the signing of a contract to fund the project SAR175 million for the construction of a disease diagnosis regional reference veterinary laboratory and for vaccine development and localization across Riyadh.

Saudi Arabia Veterinary Vaccine Market Segmentation:

• By Type
  • Livestock Vaccines
    • Bovine Vaccines
    • Poultry Vaccines
    • Aquaculture Vaccines
    • Others
  • Companion Animal Vaccines
    • Canine Vaccines
    • Feline Vaccines
    • Equine Vaccines
• By Technology
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others
• By Disease
  • Avian Influenza
  • Zootonic Disease
  • Foot-And-Mouth Disease
  • Rabies
  • Others
• By Route of Administration
  • Injectable Vaccines
    • Subcutaneous
    • Intramuscular
  • Intranasal
  • Others

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. SAUDI ARABIA VETERINARY VACCINE MARKET BY TYPE

5.1. Introduction

5.2. Livestock Vaccines

5.2.1. Bovine Vaccines

5.2.2. Poultry Vaccines

5.2.3. Aquaculture Vaccines

5.2.4. Others

5.3. Companion Animal Vaccines

5.3.1. Canine Vaccines

5.3.2. Feline Vaccines

5.3.3. Equine Vaccines

6. SAUDI ARABIA VETERINARY VACCINE MARKET BY TECHNOLOGY

6.1. Introduction

6.2. Live Attenuated Vaccines

6.3. Inactivated Vaccines

6.4. Toxoid Vaccines

6.5. Recombinant Vaccines

6.6. Others

7. SAUDI ARABIA VETERINARY VACCINE MARKET BY DISEASE

7.1. Introduction

7.2. Avian Influenza

7.3. Zootonic Disease

7.4. Foot-And-Mouth Disease

7.5. Rabies

7.6. Others

8. SAUDI ARABIA VETERINARY VACCINE MARKET BY ROUTE OF ADMINISTRATION

8.1. Introduction

8.2. Injectable Vaccines

8.2.1. Subcutaneous

8.2.2. Intramuscular

8.3. Intranasal 

8.4. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Boehringer Ingelheim International GmbH

10.2. Virbac

10.3. Al-Emar International (ARASCO)

10.4. Alkhoraif Veterinary Company

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

Companies Profiled

Boehringer Ingelheim International GmbH

Virbac

Al-Emar International (ARASCO)

Alkhoraif Veterinary Company

Related Reports